Lumos Pharma Net Tangible Assets

Lumos Pharma (LUMO) currently reports a net tangible assets of $4.9M as of September 2024. That compares with $35M in the prior-year period — down 86.2% year over year. Use the charts on this page to explore Lumos Pharma's net tangible assets history and peer comparisons.

Lumos Pharma's net tangible assets decreased from $35M to $4.9M — a 86.2% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lumos Pharma reported $4.9M in net tangible assets as of September 2024. That compares with $35M in the prior-year period — down 86.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $4.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lumos Pharma, and consider following LUMO for alerts when major investors trade the stock.

Lumos Pharma is classified in the Healthcare sector. On net tangible assets, it currently shows $4.9M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LUMO with unrelated industries.